加载中…
个人资料
  • 博客等级:
  • 博客积分:
  • 博客访问:
  • 关注人气:
  • 获赠金笔:0支
  • 赠出金笔:0支
  • 荣誉徽章:
正文 字体大小:

2012英语二Text  3

(2017-10-10 01:53:05)
标签:

2012英语二text3

杂谈

2012英语二 Text 3

 

Myriad's gene-patent battle

Gene-uinely unclear

Aug 4th 2011, 15:47 by C.H. | NEW YORK

http://www.economist.com/blogs/schumpeter/2011/08/myriads-gene-patent-battle

 

 

 

1---In 2010. a federal judge shook America's biotech industry to its core. Companies had won patents for isolated DNA for decades——by 2005 some 20% of human genes were patented. But in March 2010 a judge ruled that genes were unpatentable. Executives were violently agitated. The Biotechnology Industry Organization (BIO)a trade group, assured members that this was just a preliminary step in a longer battle.

2010, 一个联邦法官对美国生物科技行业产生了巨大影响。各家公司早就获得了单个DNA的专利,2005年大约有20%的人类基因被授予专利。但20103月,一位法官判决基因是不能授予专利的。执行高管们一下燥热不安。生物科技行业组织(BIO)是贸易组织,该组织认为这个判决是长期斗争的一个前奏。

 31. It can be learned from paragraph 1 that the biotech companies would like

  A. their executives to be active

  B. judges to rule out gene patenting 正反

  C. genes to be patentable

  D. the BIO to issue a warning 主观推导

 

2--- On July 29th they were relieved, at least temporarily. A federal appeals court overturned the prior decision, ruling that Myriad Genetics could indeed hold patents to two genes that help forecast a woman's risk of breast cancer. The chief executive of Myriad, a company in Utah, said the ruling was a blessing to firms and patients alike.

729日,他们放松了一下,至少暂时放松了一会儿。联邦上诉法院推翻了前面的判决,认为Myriad Genetics的确可以持有的两个帮助预测女性乳腺癌的基因专利。位于犹他州的Myriad首席执行官说,这个判决对于公司和患者都是一种赐福。

 

3---But as companies continue their attempts at personalized medicine, the courts will remain rather busy. The Myriad case itself is probably not over. Critics make three main arguments against gene patents: a gene is a product of nature, so it may not be patented; gene patents suppress innovation rather than reward it; and patents' monopolies restrict access to genetic tests such as Myriad's. A growing number seem to agree. Last year a federal task-force urged reform for patents related to genetic tests. In October the Department of Justice filed a brief in the Myriad case, arguing that an isolated DNA molecule “is no less a product of nature... than are cotton fibres that have been separated from cotton seeds.”  Despite the appeals court's decision, big questions remain unanswered. For example, it is unclear whether the sequencing of a whole genome violates the patents of individual genes within it. The case may yet reach the Supreme Court

 但是,正当公司继续试图个性化医疗的时候,法院将继续忙于此事。Myriad案本身可能不会结束。批评人士有三个理由反对基因专利:基因是自然的产物,所以不可以给予专利;基因专利不会鼓励创新反而会打压创新;基因垄断企业比如Myriad会限制其它公司进行基因测试。越来越多的人似乎同意这种说法。去年,联邦特派组敦促基因检测专利改革。十月,司法部在Myriad案中发表声明,单个DNA分子和从棉籽上分离出来的棉纤维一样,都是自然的产物。尽管上诉法院作出这样的判决,但是重要的问题仍然没有得到回答。比如说,基因组序列是否违背了其中单个基因专利仍无定论,这个问题可能要到最高法院裁决。

 

 genome ['dʒi:nəum] n. 基因组, 染色体组

 

 

32. Those who are against gene patents believe that

  A. genetic tests are not reliable 无中生有

  B. only man-made products are patentable 第一个理由,自然的产物不能给专利

  C. patents on genes depend much on innovation 自然产物,不是创新来的,

  D. courts should restrict access to genetic tests 偷换主语,patents' monopolies

 

4---As the industry advances, however, other suits may have an even greater impact. Companies are unlikely to file many more patents for human DNA molecules——most are already patented or in the public domain. Firms are now studying how genes interact, looking for correlations that might be used to determine the causes of disease or predict a drugs efficacy. Companies are eager to win patents for connecting the dots, explains Hans Sauer, a lawyer for the BIO

      但是,随着该行业的发展,其它的案例可能会有更大的影响力。公司不大可能申请到更多的人类DNA专利——有些已经被其它公司申请或者处于共同申请的领域。公司正在研究基因是如何相互作用的,基因的相关性可以用来判断疾病的起因或者预测药物的功效。BIO的律师Hans Sauer解释道,公司渴望获得专利来以便归纳推理得出结论。

注:connect the dotsTo link together logically related elements in order to draw a conclusion

 

  33. According to Hans Sauer, companies are eager to win patents for----

  A. establishing disease correlations

  B. discovering gene interactions 

  C. drawing pictures of genes

  D. identifying human DNA

本题A我认为错误的原因是文章只提到  gene correlations,没有提到 diseasecorrelation,文章只提到disease的原因。公司想获得专利的东西是:1how genes interact 2determine the causes of disease 3predict a drugs efficacy ,所以只有B和第一个吻合。

 

5---Their success may be determined by a suit related to this issue, brought by the Mayo Clinic, which the Supreme Court will hear in its next term. The BIO recently held a convention which included sessions to coach lawyers on the shifting landscape for patents. Each meeting was packed

他们是否成功可能要由Mayo Clinic带来的这个案件的诉讼情况决定。最高法院将在下一轮审理此案。生物科技行业组织(BIO)最近开会讨论聘用律师来处理摇摆不定的专利案。每个会议都人满为患。

 

34. By saying “each meeting was packed” (line4,para6) the author means that

A. the Supreme Court was authoritative

B. the BIO was a powerful organization

C. gene patenting was a great concern(主题词)比D

D. lawyers were keen to attend conventions

 

35. Generally speaking, the author’s attitude toward gene patenting is

A. critical           B. supportive         C. scornful               D. objective

0

阅读 收藏 喜欢 打印举报/Report
  

新浪BLOG意见反馈留言板 欢迎批评指正

新浪简介 | About Sina | 广告服务 | 联系我们 | 招聘信息 | 网站律师 | SINA English | 产品答疑

新浪公司 版权所有